Aricept

Type: Product
Name: Aricept
First reported 11 hours ago - Updated 35 mins ago - 2 reports

Pfizer Beats on Q2 Earnings, Revs Despite Generic Pressures

Pfizer Inc. ( PFE - Analyst Report ) posted second quarter 2014 earnings of 58 cents per share, a couple of cents above the Zacks Consensus Estimate and 4% above the year-ago earnings. Revenues, which declined 2% to $12.8 billion, were above the Zacks ... [Published Zacks.com - 11 hours ago]
First reported 10 hours ago - Updated 10 hours ago - 1 reports

To Solve Alzheimer’s Mystery, Better Biological Clues Sorely Needed

The other day, I found a video on the website of the Alzheimer’s Association, a nonprofit foundation. It was part of an HBO documentary series produced a few years ago by Maria Shriver to educate the public about Alzheimer’s disease.The first couple minutes ... [Published Xconomy - 10 hours ago]
First reported Jul 21 2014 - Updated Jul 21 2014 - 1 reports

Anavex Life Sciences : Achieves Key Milestone as it Secures cGMP Manufacturing for Drug Candidate Trial Supplies

(GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. ("Anavex" or the "Company") (OTCQB:AVXL), a clinical-stage biopharmaceutical company developing novel drug candidates to treat Alzheimer's disease, other diseases of the central nervous system (CNS) and various ... [Published 4 Traders - Jul 21 2014]
First reported Jul 18 2014 - Updated Jul 18 2014 - 1 reports

"Non-Mucoadhesive Film Dosage Forms" in Patent Application Approval Process

By a News Reporter-Staff News Editor at Drug Week A patent application by the inventors Leichs, Christian (Burscheid, DE); Breitenbach, Armin (Leverkusen, DE); Lehrke, Ingo (Koln, DE); Galfetti, Paolo (IT, IT), filed on October 11, 2013, was made available ... [Published Pharmacy Choice - Jul 18 2014]
First reported Jul 16 2014 - Updated Jul 17 2014 - 1 reports

Arthritis drug could also halt Alzheimer's: Treatment found to stop progression of memory loss and poor mood

| Updated: 16:40 EST, 16 July 2014A safe and widely-used arthritis drug stops Alzheimer’s in its tracks, a British study has found.The 20 men and women who were given Etanercept did not descend further into the disease – unlike those who were given a ... [Published Mail Online UK - Jul 16 2014]
First reported Jul 15 2014 - Updated Jul 15 2014 - 3 reports

Targacept admits failure in Alzheimer’s trial

Targacept is dropping a once promising Alzheimer’s drug from further clinical trials after it failed to beat Pfizer’s Aricept (donepezil) in a mid-stage study.The US biotech firm confirmed today that the Phase IIb trial of TC-1734, as a treatment for ... [Published Pharmafocus - Jul 15 2014]
First reported Jul 15 2014 - Updated Jul 15 2014 - 1 reports

Morning Break: Smart Lenses, 'I'm Not Dead!'

OphthalmologyPublished: Jul 15, 2014By MedPage Today StaffNovartis said its Alcon division would use Google technology to develop a "smart" contact lens that could monitor glucose levels while correcting presbyopia.The firm also announced that it would ... [Published MedPage Today - Jul 15 2014]
First reported Jul 07 2014 - Updated Jul 08 2014 - 1 reports

Lexicon Announces Appointment of Lonnel Coats as President and Chief Executive Officer

/PRNewswire/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced today that Lonnel Coats has been appointed president and chief executive officer effective July 7, 2014. Mr. Coats most recently served as president and chief executive officer of ... [Published BusinessWeek - Jul 07 2014]
First reported Jul 07 2014 - Updated Jul 07 2014 - 1 reports

7 Proven Ways to Keep Your Brain Young

Alzheimer’s disease affects about 5.3 million Americans. It’s the leading cause of dementia and the 6 th leading cause of death in the U.S.  And it’s growing at an alarming rate.  Already 13% of people over 65 have been diagnosed with the disease.  An ... [Published Epoch Times - Jul 07 2014]
First reported Jul 07 2014 - Updated Jul 07 2014 - 1 reports

Eisai : CEO more like founding father

When one thinks about the so-called company lifer, one envisions an individual who arrives at the of ce one day and returns for the next 8,750, to the extent that said individual becomes as much a fixture as the company's physical structures. But while ... [Published 4 Traders - Jul 07 2014]
First reported Jul 02 2014 - Updated Jul 02 2014 - 1 reports

Global Alzheimer Disease Patients Market & Drugs Analysis 2015...

MarketReportsOnline.com adds "Alzheimer’s Disease Patients & Market Worldwide, Future Scenario (2010 – 2015) & Drugs Analysis" report to its research store. Alzheimer’s is a complex disease and there is no single “magic bullet” available in the market ... [Published PRWeb - Jul 02 2014]
First reported Jun 13 2014 - Updated Jun 13 2014 - 1 reports

newbie

Hello,I'm new to the boards. My mom has dementia and has been on aricept and namenda for over 8 years. She has been sundowning for the past year, getting very agitated and talking to people who have been dead over fifty years. She stays with me at ... [Published HealthBoards - Jun 13 2014]
Entities: Aricept

Quotes

"Overall, I am pleased with our second-quarter 2014 financial results despite the continued negative impact from product losses of exclusivity and the termination of certain co-promotion collaborations. We updated our 2014 adjusted revenue guidance to reflect the anticipated negative impact associated with expected multi-source generic competition for Celebrex in the U S beginning in December 2014" CFO Frank D'Amelio said in a statement
"Higher levels on both glucose measures were associated with worse memory, as well as a smaller hippocampus and compromised hippocampal structure."
...(API) manufactured and available for our Phase 2a trial," said Christopher U Missling , PhD, President and Chief Executive Officer of Anavex. "We look forward to initiating clinical trials with ANAVEX PLUS for the treatment of Alzheimer's disease, which remains on track to commence in 2014 with data from the first part of the trial expected to be reported in mid 2015."
"In another embodiment, the film strip of the present invention, or the immediate release dosage form, can be defined by its pharmacokinetics, and in one embodiment, the film strip or immediate release dosage form has an absolute bioavailability of greater than 65%, 75%, 85% or even 95% when administered orally. In another embodiment, the film strip or immediate release dosage form has an absolute bioavailability that is greater than about 45%, 50%, or 55%, and peak plasma concentrations (C.sub.max) in less than 3.0, 2.5 or 2.0 hours. Finally, because the film dosage form is specially formulated or administered for gastrointestinal absorption, the film dosage form has a comparable absolute bioavailability or T sub.max as an immediate release tablet or capsule or orally dissolving/dispersing tablet (ODT) that comprises the same amount of active pharmaceutical agent."

More Content

All (32) | News (27) | Reports (0) | Blogs (4) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
To Solve Alzheimer’s Mystery, Better Biological... [Published Xconomy - 10 hours ago]
Pfizer Beats on Q2 Earnings, Revs Despite Gener... [Published Zacks.com - 11 hours ago]
Pfizer Beats Forecasts Despite Slumping Sales [Published RTTNews.com - 11 hours ago]
Eisai:R&I Affirms AA-/a-1+,Changes Outlook to N... [Published Noodls - Jul 28 2014]
How Sugar Harms Your Brain Health and Drives Al... [Published Mercola - Jul 24 2014]
Anavex Life Sciences : Achieves Key Milestone a... [Published 4 Traders - Jul 21 2014]
"Non-Mucoadhesive Film Dosage Forms" in Patent ... [Published Pharmacy Choice - Jul 18 2014]
Arthritis drug could also halt Alzheimer's: Tre... [Published Mail Online UK - Jul 16 2014]
Ted Rall: Moths to Flame [Published River Cities Reader - Jul 16 2014]
Alzheimer’s Drug Fails Mid-Stage Study [Published P&T Community - Jul 15 2014]
Morning Break: Smart Lenses, 'I'm Not Dead!' [Published MedPage Today - Jul 15 2014]
Targacept admits failure in Alzheimer’s trial [Published Pharmafocus - Jul 15 2014]
Targacept pulls plug on Alzheimer's candidate [Published Pharma Times - Jul 15 2014]
Targacept terminates development of experimenta... [Published FirstWord Pharma - Jul 15 2014]
Targacept's Alzheimer's hopeful misses the mark... [Published FierceBiotech - Jul 14 2014]
Tunes Could Bring Back Memories Lost to Alzheim... [Published Mercola - Jul 10 2014]
A Drug to Prevent Alzheimer's [Published Texomashomepage.com - Jul 10 2014]
Lexicon Announces Appointment of Lonnel Coats a... [Published BusinessWeek - Jul 07 2014]
7 Proven Ways to Keep Your Brain Young [Published Epoch Times - Jul 07 2014]
Eisai : CEO more like founding father [Published 4 Traders - Jul 07 2014]
Ted Rall: We, the Corporations [Published River Cities Reader - Jul 06 2014]
Global Alzheimer Disease Patients Market & Drug... [Published PRWeb - Jul 02 2014]
Alzheimer's and dementia devastate caregivers a... [Published Beaver County Times - Jun 20 2014]
Charity Awards Finalist: Rx Outreach, Inc. [Published Ladue News - Jun 20 2014]
newbie [Published HealthBoards - Jun 13 2014]
A Look at Pfizer’s Recent Financial Performance [Published Wall St. Cheat Sheet - May 15 2014]
Anavex Strengthens Scientific Advisory Board Wi... [Published GlobeNewswire - May 12 2014]
Chase Pharmaceuticals Corporation inks $21 mln ... [Published PE Hub Blog - May 12 2014]
Eisai and Biogen partner to develop new treatme... [Published Pharmaceutical Technology - Mar 07 2014]
Hello, new here [Published HealthBoards - Mar 01 2014]
1 2
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
newbie [Published HealthBoards - Jun 13 2014]
Hello,I'm new to the boards. My mom has dementia and has been on aricept and namenda for over 8 years. She has been sundowning for the past year, getting very agitated and talking to people who have been dead over fifty years. She stays with me at ...
A Look at Pfizer’s Recent Financial Performance [Published Wall St. Cheat Sheet - May 15 2014]
Pfizer ( NYSE:PFE ) is getting a lot of attention lately, mostly given its potential deal with AstraZeneca ( NYSE:AZN ). This topic has been thoroughly covered lately. But despite the drama surrounding the headlines of late, Pfizer is still my ...
Chase Pharmaceuticals Corporation inks $21 mln ... [Published PE Hub Blog - May 12 2014]
Chase Pharmaceuticals Corporation has raised a $21 million Series B financing led by New Rhein Healthcare Investors . Other new investors include Edmond de Rothschild Investment Partners and Cipla Ventures , the new venture capital arm of Cipla ...
Hello, new here [Published HealthBoards - Mar 01 2014]
Hello,My name is Lisa and I have been my mom's caregiver since December. I had been trying to get her (now "ex") husband to get her diagnosed for over 2 years and nothing was done, so as soon as I got her here, I took her to a GP and immediately had a ...
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.